BioSpace News Archive

Orthofix Medical Inc today announced that Thomas A. West has been named to the Company’s Board of Directors and appointed to the Compensation and Talent Development Committee.

Vera Therapeutics, Inc. today announced the appointment of Kimball Hall to its board of directors.

Centessa Pharmaceuticals plc together with subsidiary Palladio Biosciences, Inc. today announced the initiation of active recruitment of the global ACTION Study, a pivotal Phase 3 clinical trial evaluating lixivaptan as a potential treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it intends to offer $250.0 million aggregate principal amount of its Convertible Senior Notes due 2028 (the “notes”) in a private offering (the “offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Medtronic plc today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS™ 7100 cerebral/somatic oximetry system for children from birth through age 18.

HemoShear Therapeutics, Inc. has appointed Patrick Horn , MD, PhD, as Chief Medical Officer, effective January 1, 2022.

Infinity Pharmaceuticals, Inc. today announced it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI), effective as of market open on Monday, December 20, 2021.

I-Mab reported interim data from an ongoing clinical trial of lemzoparlimab in combination with rituximab in heavily treated patients with relapsed or refractory non-Hodgkin’s lymphoma, at the 63rd American Society of Hematology Annual Meeting.

Astrocyte Pharmaceuticals Inc., a drug discovery and development company developing novel cerebroprotective therapeutics for patients with brain injuries, announced that Christine Gallagher has joined the company’s Board of Directors.

CB Scientific, Inc. announced that the company has entered the Beta testing phase for its updated My-Cam cardiac event monitoring device.